Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» oncology
oncology
The state of the oncology microbiome therapeutics pipeline at a glance
Clinical Trials Arena
Fri, 03/10/23 - 11:23 am
oncology
cancer
microbiome
drug development
Lantern Pharma announces plans to enhance oncology drug discovery
Outsourcing Pharma
Tue, 02/21/23 - 10:24 am
Lantern Pharma
drug discovery
oncology
machine learning
artificial intelligence
On the turnaround trail, tiny Corbus pays $7.5M for rival to Seagen's oncology ADC Padcev
Fierce Biotech
Mon, 02/13/23 - 10:29 am
Corbus Pharmaceuticals
Seagen
Padcev
CRB-701
oncology
Medable and Nova Scotia Health Partner to Improve Oncology Trial Access Through Decentralized Clinical Trial Technology
Xtalks
Fri, 02/10/23 - 11:02 am
clinical trials
Medable
Nova Scotia
oncology
decentralized clinical trials
Oncolytic virus startup TILT raises €22M to advance cancer therapies
Endpoints
Tue, 02/7/23 - 11:05 am
TILT Biotherapeutics
oncolytic viruses
clinical trials
cancer
oncology
BMS returns $475M IL-12 oncology asset to Dragonfly’s pond
Fierce Biotech
Mon, 02/6/23 - 06:12 pm
Dragonfly Therapeutics
Bristol Myers Squibb
oncology
DF6002
solid tumors
Oncology, HIV sales lift Gilead’s revenues by 2%
Medical Marketing and Media
Thu, 02/2/23 - 11:09 pm
Gilead Sciences
earnings
HIV
oncology
hepatitis C
Immuno-oncology goes subcutaneous
EP Vantage
Wed, 01/25/23 - 10:18 am
immuno-oncology
oncology
subcutaneous drug delivery
Keytruda
Merck
Tecentriq
Roche
Bayer’s oncology business looks to collect $10B in sales by 2030, exec says
Fierce Pharma
Tue, 01/24/23 - 10:38 am
Bayer
oncology
prostatce caner
Nubeqa
Christine Roth
Is mesothelin a key to tackling solid tumors? Some biotech companies are betting that it is
Stat
Sun, 01/22/23 - 01:05 pm
cancer
oncology
mesothelin
solid tumors
FDA details approach for finding optimal dosages for new cancer drugs
RAPS.org
Wed, 01/18/23 - 10:42 am
FDA
oncology
cancer
regulatory
Chasing Roche, Merck talks up subcutaneous Keytruda ahead of phase 3 data drop
Fierce Pharma
Mon, 01/16/23 - 11:16 am
Merck
Keytruda
Roche
cancer
oncology
BMJ finds 96% of oncology drug developers inadequately include minority groups
Clinical Trials Arena
Fri, 01/13/23 - 11:06 am
BMJ
FDA
oncology
minorities
drug development
Lawmakers again urge the Biden administration to use federal law to widen access to a cancer drug
Stat
Wed, 01/11/23 - 10:51 am
cancer
oncology
Joe Biden
Astellas
Xtandi
prostate cancer
AbbVie, following in footsteps of Lilly and Takeda, pays Anima $42M to go after undruggable targets
Fierce Biotech
Tue, 01/10/23 - 11:05 am
AbbVie
Anima Biotech
MRNA
small molecule drugs
oncology
immunology
undruggable targets
UK signs deal with BioNTech for cutting-edge cancer trials
Financial Times
Fri, 01/6/23 - 09:35 am
BioNTech
UK
cancer
oncology
clinical trials
Biopharmas left Black and Latinx patients behind in oncology clinical trials, nonprofit says
Fierce Biotech
Thu, 01/5/23 - 10:09 am
clinical trials
clinical trial diversity
oncology
Sanofi
United Therapeutics
Bristol Myers Squibb
Merck Expands ADC Footprint with $9.3B Kelun Licensing Deal
BioSpace
Thu, 12/22/22 - 10:44 am
Merck
China
Kelun-Biotech
antibody-drug conjugate
oncology
Biosimilars hit a turning point as they expand outside oncology
Clinical Trials Arena
Fri, 12/9/22 - 10:31 am
biosimilars
oncology
immunology
gastroenterology
ophthalmology
Respiratory
dermatology
metabolic disorders
musculoskeletal disorders
Cancer drugmaker Plexxikon gets new life as Opna Bio
BioPharma Dive
Tue, 11/22/22 - 10:38 am
Plexxikon
Opna Bio
rebranding
oncology
Daiichi Sankyo
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »